Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.002

€0.002

-16.670%
-0.0003
-16.670%
-
 
23.02.24 / Stuttgart Stock Exchange WKN: A3DR5C / Name: Spineway / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Spineway Stock

Heavy losses for Spineway today as the stock fell by -€0.000 (-16.670%).
For the coming years our community has positive and negative things to say abot the Spineway stock. Criterium "Market Position" gathered the most positive votes but regarding "Growth compared to competition" there were negative voices in the community.

Pros and Cons of Spineway in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Spineway vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Spineway -16.670% -21.053% -81.707% -99.862% -25.000% -99.998% -
Crossject S.A. 1.350% -5.170% -26.848% -22.872% -17.181% 1.348% 60.000%
Implanet S.A. -1.930% -3.614% -3.614% -58.021% 5.066% -95.172% -98.627%
Visiomed Group 1.240% 1.661% 6.158% -20.261% -5.116% -63.188% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-29

Based on the provided financial statements, the general impression of Spineway is that of a company in the Healthcare Equipment & Supplies industry that has experienced growth in recent years, with some improvements in its financial performance. However, there still remain certain areas of concern that require further attention and analysis to better understand its overall financial health.

Growing total assets: The total assets of Spineway have consistently increased over the past few years, with a significant growth from €12,375,771 in 2019 to €25,247,996 in 2021. This is an indication of the company's ability to expand its business operations and potentially generate higher revenues.

Increasing stockholders' equity: The total stockholder equity has experienced steady growth - from €6,431,048 in 2019 to €21,325,795 in 2021. An increase in stockholders' equity is generally a positive signal as it suggests that the company has been successful in retaining earnings and raising additional capital.